Clinical Trial Update: A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating azacitidine in combination with venetoclax for acute myeloid leukemia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Azacitidine (Vidaza) (azacitidine)
• Venetoclax (Venclyxto) (venetoclax)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Acute Myeloid Leukemia (AML) | Phase 2 | Status: RECRUITING